Showing results (571-580 of 607) with videos related to

Sort By:
Pageof 61
BMC Psychiatry|July 19, 2022
The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditionsC Carswell, J V E Brown, J Lister, et al.
Archives of Disease in Childhood|August 14, 2024
Children and young people's preferences and needs when using health technology to self-manage a long-term condition: a scoping reviewRosemary Jane Court, Veronica Swallow, Sarab El-Yousfi, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitorsDavid K Williams, Xiao-Tao Chen, Christine Tarby, et al.
Frontiers in Health Services|December 12, 2025
The DIAMONDS intervention for type 2 diabetes for people with severe mental illness: findings from a single-group feasibility studyJ V E Brown, C Carswell, D Podmore, et al.
Frontiers in Psychiatry|September 7, 2021
Determinants of Physical Health Self-Management Behaviours in Adults With Serious Mental Illness: A Systematic ReviewPeter A Coventry, Ben Young, Abisola Balogun-Katang, et al.
Global Change Biology|January 16, 2023
A surplus no more? Variation in krill availability impacts reproductive rates of Antarctic baleen whalesLogan J Pallin, Nick M Kellar, Debbie Steel, et al.
Community Dentistry and Oral Epidemiology|January 8, 2024
Behaviour change intervention for toothbrushing (lesson and text messages) to prevent dental caries in secondary school pupils: The BRIGHT randomized control trialNicola Innes, Caroline Fairhurst, Katie Whiteside, et al.
BMJ Open|March 27, 2025
DIAMONDS-a diabetes self-management intervention for people with severe mental illness: protocol for an individually randomised controlled multicentre trialGrace Catherine O'Carroll, Jennifer V E Brown, Claire Carswell, et al.
Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
Pageof 61